Chloroquine (Lariago (60 ml)) is used for the treatment of Malaria, Rheumatoid Arthritis, Lupus Erythematosus & COVID-19 Infection.
Mechanism of action: It acts by blocking the action of enzyme ‘heme polymerase’ in malarial parasites and this leads to accumulation of heme - which is toxic to the malarial parasite. This leads to the death of the malarial parasite.
Update:
•FDA warns against the use of Chloroquine (Lariago (60 ml)) or hydroxyChloroquine (Lariago (60 ml)) for treating COVID-19 outside the hospital setting or a clinical trial due to high risk of heart rhythm issues.
• Chloroquine (Lariago (60 ml)) and hydroxyChloroquine (Lariago (60 ml)) gained attention in spite of sayings by the World Health Organization (WHO) that there is no definitive evidence they work for COVID-19 patients.
• Larger, high-quality randomized clinical trials may be needed in order to precisely evaluate its effectiveness, according to University of Oxford's Kome Gbinigie, author of a report on anti-malarial testing for Covid-19.
• More than 20 trials are being carried out on Chloroquine (Lariago (60 ml)) for treating COVID-19 in the US, UK, Spain, and China.
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak with a healthcare professional.
Generic : Chloroquine
Price Updated on August 08, 2019
Mechanism of action: It acts by blocking the action of enzyme ‘heme polymerase’ in malarial parasites and this leads to accumulation of heme - which is toxic to the malarial parasite. This leads to the death of the malarial parasite.
Update:
•FDA warns against the use of Chloroquine (Lariago (60 ml)) or hydroxyChloroquine (Lariago (60 ml)) for treating COVID-19 outside the hospital setting or a clinical trial due to high risk of heart rhythm issues.
• Chloroquine (Lariago (60 ml)) and hydroxyChloroquine (Lariago (60 ml)) gained attention in spite of sayings by the World Health Organization (WHO) that there is no definitive evidence they work for COVID-19 patients.
• Larger, high-quality randomized clinical trials may be needed in order to precisely evaluate its effectiveness, according to University of Oxford's Kome Gbinigie, author of a report on anti-malarial testing for Covid-19.
• More than 20 trials are being carried out on Chloroquine (Lariago (60 ml)) for treating COVID-19 in the US, UK, Spain, and China.
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak with a healthcare professional.
Lariago (60 ml) - Ipca Laboratories Ltd. (Intima)
Lariago (60 ml) Suspension
Generic : Chloroquine
₹
15.6
50mg/5ml
60ml
Substitute/Alternative Medication to Lariago (60 ml)
Amoquin | Amoquin (250 mg) | Antima | Apaquine | Arquin | Arquin (450 ml) | Arquin (60 ml) | Bitaquine | Bitaquine (10ml) | Bitaquine (30 ml)
When is Lariago (60 ml) prescribed?
It is prescribed for -
